(MedPage Today) — A systematic review suggested that drugs targeting amyloid beta appeared to have no clinically meaningful positive effects, sparking swift backlash from Alzheimer’s disease experts.
The review assessed 17 trials conducted between…
Source:
www.medpagetoday.com
Medical Disclaimer:
This content is shared for informational and educational purposes only.
It does not constitute medical, legal, or policy advice.
Healthcare decisions should always be made in consultation with qualified professionals.
